Policy | September 20, 2021
India to resume export of Covid-19 vaccines from October
The country’s vaccine production has more than doubled since April and is set to touch 300 million doses next month
The country’s vaccine production has more than doubled since April and is set to touch 300 million doses next month
Everest gains access to a clinically validated mRNA platform and a potentially “best-in-class” mRNA COVID-19 vaccine with full technology transfer
The value of the contract is estimated to be between Rs 20-30 crores per year for the next three years
CDSCO to fast-track trials and approval for COVID19 vaccine
With a mix of vaccines targeting different stages of COVID-19, the company is eyeing huge market potential
Subscribe To Our Newsletter & Stay Updated
